Endocrinology

The Endocrinology Revenue Reality

Endocrinology is documentation-driven and longitudinal in nature. Small recurring denials compound across chronic-care volume.

• E/M level downcoding
• Medical necessity denials for lab panels
• Frequency limits on A1C and metabolic testing
• CGM and insulin pump documentation gaps
• Remote Patient Monitoring (RPM) coding errors
• Chronic Care Management (CCM) time tracking issues
• Device supply reimbursement variance
• AR accumulation tied to recurring visits

E/M & Chronic Care Coding Precision (CCP)

• E/M documentation alignment
• CCM and RPM time tracking verification
• Modifier governance
• Device-related CPT validation
• Add-on code accuracy checks

Target Outcome: Reduced downcoding and improved first-pass acceptance.

Lab & Frequency Rule Controls (FIO + EAE)

• Frequency limit monitoring
• Diagnosis-to-lab CPT alignment
• Coverage validation for advanced testing
• Authorization checks where applicable

Target Outcome: Fewer recurring lab-related denials.

AR Optimization for Recurring Visits (AAF)

• Structured follow-up on aging balances
• Chronic care denial appeals
• Device reimbursement tracking
• AR > 90 monitoring by CPT category

Target Outcome: Improved revenue consistency.

Device & Reimbursement Pattern Intelligence (PRL)

• CGM and insulin pump reimbursement variance
• Denial clustering by lab CPT
• Downcoding trends by payer
• AR aging by chronic-care category

Target Outcome: Clear visibility into recurring chronic-care revenue gaps.

Measurable Performance Targets

• 8–18% increase in net collections
• 15–30% reduction in denial rates
• 25–40% reduction in AR > 90
• 95–98% first-pass claim acceptance
• Faster resolution of chronic-care appeals

Compliance & Infrastructure

• HIPAA-compliant workflows with BAA signed prior to PHI exchange
• Integration with major EHR platforms including Epic, Cerner, Athenahealth, NextGen, eClinicalWorks and others
• Cybersecurity oversight via Redfort Technologies
• U.S.-based nationwide operations